Surveillance for Early Liver Injuries Caused by Yangxue Shengfa Capsule.
NCT03113838 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2017-04-14
Summary
This is a prospective registry study to surveil early liver injuries caused by Yangxue Shengfa Capsule (YXSF Capsule) through a non-intervention observational way. And attempt to establish a predictive model to screen susceptibilities to YXSF Capsule.
Conditions
- Drug-Induced Liver Injury
Sponsors & Collaborators
-
Beijing 302 Hospital
lead OTHER
Principal Investigators
-
Xiao-he Xiao · 302 Military Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-04-17
- Primary Completion
- 2017-12-31
- Completion
- 2017-12-31
Countries
- China
Study Locations
More Related Trials
-
Assessment of Liver Fibrosis and Prognosis in Chinese Patients With CHB Infection Using STE/STQ Elastography
NCT03530657 ·Status: UNKNOWN
-
The Diagnostic Value of Subharmonic Imaging Technology Combined With Liver Stiffness and Platelet Count for High-risk Esophageal and Gastric Varices in Patients With Liver Cirrhosis
NCT07151885 ·Status: RECRUITING ·Phase: NA
-
Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease
NCT02060565 ·Status: RECRUITING
-
Evaluation of Intra-operative Ultrasound Contrast Enhancement in the Evaluation of Liver Tumors
NCT00955097 ·Status: TERMINATED ·Phase: PHASE1
-
Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver Transplantation
NCT03490461 ·Status: COMPLETED
-
Non-invasive Prediction of Esophageal Varices in Liver Cirrhosis: A Multicenter Observational Study
NCT02593799 ·Status: COMPLETED
-
Prophylactic Antibiotics Before RFA for HCC
NCT02534961 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of Patients With Liver Disease
NCT00001971 ·Status: RECRUITING
-
A Prospective/Retrospective, Observational Follow-up Study of Chronic Hepatitis B With Non-alcoholic Fatty Liver Disease.
NCT05255978 ·Status: RECRUITING
-
ShearWave™ Elastography to Assess Liver Fibrosis in Chinese Patients With Hepatitis B
NCT02313649 ·Status: COMPLETED
-
Study of Hemodynamic Conditions Measured During Hepatectomy
NCT03371537 ·Status: COMPLETED
-
Evaluation of Liver Fibrosis With 2D-Shear Wave Elastography
NCT04759521 ·Status: COMPLETED
-
A Comparison Between Child-Pugh and Albumin-Bilirubin Scores
NCT03534843 ·Status: COMPLETED
-
Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure
NCT07275554 ·Status: RECRUITING
-
Identification of Protective and Worsening Steatohepatitis (NASH) Factors
NCT00914446 ·Status: UNKNOWN ·Phase: NA
-
Prophylactic Treatment of Hepatic Dysplastic Nodules in HBsAg Positive Patients
NCT02793791 ·Status: UNKNOWN ·Phase: NA
-
Comparing Pain in Patients Undergoing Percutaneous Versus Transjugular Techniques of Liver Biopsy
NCT02311348 ·Status: COMPLETED
-
Evaluating the Association Between Sphingolipid Metabolites and Post-hepatectomy Liver Failure
NCT03598465 ·Status: COMPLETED
-
Non-invasive Diagnosis of Non-alcoholic Steatohepatitis in Liver Transplant Recipients
NCT03128918 ·Status: UNKNOWN
-
Use of Shear Wave Elastography to Assess Non-alcoholic Fatty Liver Disease (NAFLD)
NCT03587298 ·Status: UNKNOWN
-
Fatty Acids, Genes and Microbiota in Fatty Liver
NCT02148471 ·Status: COMPLETED
-
Clinical Application of Non-invasive Assessment for Staging Liver Steatosis and Liver Fibrosis
NCT03386890 ·Status: UNKNOWN
-
Outcomes and Risk Factors for Liver Transplantation Using Significant Fibrotic Grafts
NCT07101718 ·Status: COMPLETED
-
Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)
NCT04883177 ·Status: COMPLETED
-
Safety and Adequacy of Trans-jugular Liver Biopsy in Patients With Liver Disease: SAFE-TJLB Study
NCT06469489 ·Status: RECRUITING